Northwire Canada EditionThursday, July 16, 2026
Sign inSubscribe
Northwire
⌕
CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6% CLCH 1.17 −4.1% DG 0.035 +0.0% SGML 15.86 −6.0% FURY 0.730 −2.7% CG 22.11 −1.9% ARIS 20.18 −1.1% LAF 1.65 +0.0% MKO 10.18 −2.2% NUG 0.330 −1.5% SGN 0.250 −5.7% AVL 7.99 −0.4% ELE 22.14 −2.7% TRX 1.03 −7.2% PTM 1.83 +0.6% OMM 0.050 −9.1% CBG 0.300 −1.6%
Regulatory

Zefiro Founder and Former Chairman Provides Details of Entrenchment Tactics to be Subject to Upcoming BCSC Hearing

By The Northwire Desk — AI Analysis Feb 17, 2026 · 07:00 ZEFI · 0.43 ZEFIRO METHANE CORP.
ZEFI · Price

Executive Summary

  • Concerned shareholders (Dr. Talal A. Debs, X Machina Capital Strategies and X Machina Sustainable Technologies) will request the British Columbia Securities Commission to intervene in a proxy contest, alleging oppressive defensive tactics by Zefiro Methane Corp.’s board.
  • The company issued 13,214,494 “Debt Settlement Shares” one day before the record date for the March 4, 2026 annual/general meeting, giving the recipients (including director/interim CEO Catherine Flax) ~14.6% of voting power and potentially influencing the proxy vote.
  • The shareholders seek remedies to rescind or block voting on those shares and have outlined additional alleged entrenchment actions (removal of Dr. Debs as CEO/Chair, off‑market change‑of‑control bonuses, prior share/option issuances, amendment of notice policies, breach of Investor Rights Agreement).

Key Details

  • Hearing Schedule: Tentative BCSC proceeding dates – February 25, March 3 and March 4, 2026.
  • Debt Settlement Shares: 13,214,494 shares issued one day before the record date; recipients include:
  • Catherine Flax (director & interim CEO)
  • David McGrath (founding partner of Sherman Financial Group)
  • Michael McGavick (Co‑Chairman, Bridgewater Associates)
  • Recipients collectively hold 14.6% of the company’s issued and outstanding shares, enough to affect the proxy outcome.
  • The debt underlying these shares is not due for ten months; a portion was used to pay unaccrued interest despite no obligation.
  • Other alleged entrenchment tactics:
  • Removal of Dr. Debs from CEO/Chair roles and initiation of costly investigation.
  • Employment‑agreement amendments granting generous, off‑market change‑of‑control bonuses to Ms. Flax and other executives.
  • Prior issuance (Nov 2025) of 1,127,273 shares and 400,000 options in a debt settlement.
  • Amendment of the Advance Notice Policy giving board discretion to disqualify director nominees.
  • Repeated breaches and eventual invalidation of an Investor Rights Agreement held by XMST.
  • Failure to call the annual general meeting on time.
  • Requested Remedies:
  • Rescission of the Debt Settlement Shares issuance, or
  • Prevention of those shares from voting at the March 4 meeting.
  • Potential Meeting Postponement: Dr. Debs expects a postponement to March 31, 2026 to allow shareholders to review BCSC’s decision before voting.
  • Shareholder Ownership: Dr. Debs (via XMC) controls ~23.12% of Zefiro’s common shares (20,914,750 shares). He will not vote 500,000 personally held shares per a side‑letter agreement.

Notable Quotes

“The board of directors expects shareholders to believe it was a coincidence that they decided to put 13.2 million newly issued shares into friendly hands one day before the deadline for participating in the proxy contest… We look forward to presenting the facts to the BCSC.” – Dr. Talal A. Debs, Founder and Director, Zefiro Methane Corp.

Materiality Assessment

  • Material - Negative – The disclosure details actions that could materially affect shareholder voting power, governance structure, and future control of the company, posing a significant risk to existing shareholders.
Read the original news release →

More from ZEFIRO METHANE CORP.

Jun 30, 2026 · 05:01

Zefiro pivots to data-center infrastructure remediation, but liquidity remains tight and capital-dependent.

Production / Operations Jun 17, 2026 · 05:01

Zefiro Subsidiary Awarded USD $2.4 Million in Additional Federally Funded Projects to Plug 12 Orphan Wells in Ohio

Production / Operations Jun 12, 2026 · 05:01

Small capital raise to fund equipment expansion and international debut; execution risk remains high.

Financings Jun 10, 2026 · 05:01

New corporate accounts and $19.6M Ohio contract validate fleet expansion, but liquidity constraints and working capital deficit remain the primary near-term headwinds.

Production / Operations May 26, 2026 · 05:01

Zefiro ramps up rig count from Viking acquisition, but governance scars and heavy dilution keep the growth story firmly in “show‑me” territory.

Production / Operations May 14, 2026 · 17:02

Zefiro’s Q3 earnings confirm $11M quarterly revenue, debt slashed by a third, but the loss-making remediation firm still needs to prove its $40M run-rate can turn into profits.

Earnings